Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Relyvrio (sodium phenylbutyrate/ taurursodiol)
.
Show all posts
Showing posts with label
Relyvrio (sodium phenylbutyrate/ taurursodiol)
.
Show all posts
Monday, November 14, 2022
FDA Approves Relyvrio (sodium phenylbutyrate/taurursodiol) for Patients with Amyotrophic Lateral Sclerosis (ALS)
›
In continuation of my update on phenyl butyrate and taurursodiol .. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”)...
›
Home
View web version
